Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2444090 Title: Nouvelle formulation parentérale de carbamazépine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
121507834
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2444090
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
02/10/2006
Grant date:
12/12/2018
EP publication date:
25/04/2012
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
12/12/2018
EP B1 publication date:
12/12/2018
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/10/2019
Expiration date (if granted and all annual fees paid):
02/10/2026

Applicant

Name:
Lundbeck Pharmaceuticals LLC
Legal Form:
From:
12/12/2018
Address:
6 Parkway North, Suite 400, Deerfield, IL 60015, United States (US)
To:

Inventor

1

Name:
Cloyd, James
Legal Form:
Address:
Edina, MN Minnesota 55424, United States (US)

2

Name:
Birnbaum, Angela
Legal Form:
Address:
Minneapolis, MN Minnesota 55447-1731, United States (US)

3

Name:
Leppik, Ilo
Legal Form:
Address:
Minneapolis, MN Minnesota 55427-4849, United States (US)

Priority

Priority patent number:
722692 P
Priority date:
30/09/2005
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/55;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2018/34
Publication date:
16/01/2019
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2020/16
Publication date:
13/08/2020
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
201850
Publication date:
12/12/2018
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type